Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in obesity
L. G. Hall, J. K. Czeczor, T. Connor, J. Botella, K. A. De Jong, M. C. Renton, A. J. Genders, K. Venardos, S. D. Martin, S. T. Bond, K. Aston-Mourney, K. F. Howlett, J. A. Campbell, G. R. Collier, K. R. Walder, , S. McGee
This study shows that amyloid beta 42 from adipose tissue impairs cardiac function in obesity by affecting mitochondrial metabolism, and that neutralizing A{beta} can prevent obesity-induced cardiac dysfunction.
bioRxiv · Oct 2, 2022 · PreprintPhysiology